HPLC purity
Reverse-phase HPLC with UV detection; purity target reported per lot with related-substance reporting on request.
CrystagenHPLC ≥ 99%MS confirmed20mg
Vial illustrations reflect supplied lyophilized format. Distribution scope and destination market confirmed before invoicing.
| Compound | Crystagen |
|---|---|
| Molecular formula | C14H21N3O8 |
| Molecular weight | 359.33 g/mol |
| Sequence | Glu-Asp-Pro (EDP) |
| Form | Lyophilized powder, glass vial |
| Purity target | ≥ 99% by HPLC |
| Vial formats | 20mg |
| Documentation | Batch-linked COA + HPLC chromatogram + MS identity record for every production lot |
| Distribution scope | Research use, worldwide |
| Storage | Store lyophilized powder sealed at -20°C, protected from light and moisture, for long-term stability; brief ambient exposure during shipping is tolerated. After reconstitution, keep refrigerated at 2-8°C and use within the validated period. Handle as a research material only. |
MOQ & lead time
| Tier | Quantity | Lead time |
|---|---|---|
| OEM lot | 50 kits (500 vials) | 3–7 days |
| Production lot | 500–1,000 vials | 10–14 days |
| OEM repeat | 1,000+ vials | 14–18 days, scheduled |
Supplied as a research-use peptide. Every quote confirms current-batch COA, purity, destination market and buyer track before invoicing.
Overview
About Crystagen.
Crystagen is a short synthetic peptide bioregulator from the Khavinson family, corresponding to the tripeptide sequence Glu-Asp-Pro (EDP). In published research it is characterized as an immune-system regulatory peptide, proposed to act through peptide-DNA/chromatin interactions that modulate gene expression in thymic epithelial and lymphoid cell populations.
Documentation
Batch documentation support for Crystagen lots.
batch-linked COA, HPLC chromatogram and MS identity record for every production lot. Distribution scope confirmed before invoicing.
MS identity
Mass spectrometry identity confirmation against the Crystagen reference profile.
Lot traceability
Compound prefix and lot serial printed on the vial label and repeated in the document pack and carton.
FAQ
Crystagen — frequently asked by B2B buyers.
What is Crystagen and how is it supplied?
Crystagen is a synthetic short-peptide bioregulator corresponding to the sequence Glu-Asp-Pro (EDP), part of the Khavinson bioregulator family. Pepti supplies it as a research-use lyophilized powder in 20 mg vials for laboratory and private-label applications.
What documentation ships with each batch?
Each batch is accompanied by a Certificate of Analysis reporting HPLC purity (typically ≥99%), mass-spectrometry identity confirmation against the expected molecular weight (~359.3 g/mol), and appearance and water-content data. Safety data sheets and stability information are available on request.
What is the minimum order quantity and vial size?
The standard catalog format is 20 mg per vial with a minimum order quantity of 50 kits (500 vials). Bulk peptide powder, alternative fill weights, and custom vialing are quoted separately via RFQ.
Do you offer OEM / private-label services for Crystagen?
Yes. Pepti supports OEM and private-label programs, including custom labeling, kit and packaging configuration, and documentation aligned to your specifications. COA parameters and fill weights can be tailored to your requirements.
Does Crystagen have a CAS number?
No public CAS registry number is assigned to Crystagen (Glu-Asp-Pro). Identity is instead confirmed per batch by HPLC and mass spectrometry against the expected molecular weight of approximately 359.3 g/mol, with full analytical data provided on the COA. Material is sold strictly for research use and is not for consumer, therapeutic or diagnostic use.
Related compounds